Suppr超能文献

用于结肠给药的5-氟尿嘧啶微球的特性研究

Characterization of 5-fluorouracil microspheres for colonic delivery.

作者信息

Rahman Ziyaur, Kohli Kanchan, Khar Roop K, Ali Mushir, Charoo Naseem A, Shamsher Areeg A A

机构信息

Department of Pharmaceutics, F/O Pharmacy, Hamdard University, New Delhi-110063 India.

出版信息

AAPS PharmSciTech. 2006 May 26;7(2):E47. doi: 10.1208/pt070247.

Abstract

The purpose of this investigation was to prepare and evaluate the colon-specific microspheres of 5-fluorouracil for the treatment of colon cancer. Core microspheres of alginate were prepared by the modified emulsification method in liquid paraffin and by cross-linking with calcium chloride. The core microspheres were coated with Eudragit S-100 by the solvent evaporation technique to prevent drug release in the stomach and small intestine. The microspheres were characterized by shape, size, surface morphology, size distribution, incorporation efficiency, and in vitro drug release studies. The outer surfaces of the core and coated microspheres, which were spherical in shape, were rough and smooth, respectively. The size of the core microspheres ranged from 22 to 55 microm, and the size of the coated microspheres ranged from 103 to 185 microm. The core microspheres sustained the drug release for 10 hours. The release studies of coated microspheres were performed in a pH progression medium mimicking the conditions of the gastrointestinal tract. Release was sustained for up to 20 hours in formulations with core microspheres to a Eudragit S-100 coat ratio of 1:7, and there were no changes in the size, shape, drug content, differential scanning calorimetry thermogram, and in vitro drug release after storage at 40 degrees C/75% relative humidity for 6 months.

摘要

本研究的目的是制备并评估用于治疗结肠癌的5-氟尿嘧啶结肠靶向微球。通过改良乳化法在液体石蜡中制备藻酸盐核微球,并与氯化钙交联。采用溶剂蒸发技术用Eudragit S-100包衣核微球,以防止药物在胃和小肠中释放。通过形状、大小、表面形态、粒径分布、包封率和体外药物释放研究对微球进行表征。核微球和包衣微球的外表面分别为粗糙和光滑的球形。核微球的大小范围为22至55微米,包衣微球的大小范围为103至185微米。核微球可持续释放药物10小时。在模拟胃肠道条件的pH梯度介质中进行包衣微球的释放研究。在核微球与Eudragit S-100包衣比例为1:7的制剂中,释放可持续长达20小时,在40℃/75%相对湿度下储存6个月后,微球的大小、形状、药物含量、差示扫描量热图谱和体外药物释放均无变化。

相似文献

1
Characterization of 5-fluorouracil microspheres for colonic delivery.
AAPS PharmSciTech. 2006 May 26;7(2):E47. doi: 10.1208/pt070247.
2
Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting.
AAPS PharmSciTech. 2007 Feb 16;8(1):12. doi: 10.1208/pt0801012.
3
Eudragit-coated dextran microspheres of 5-fluorouracil for site-specific delivery to colon.
Drug Deliv. 2016;23(1):328-37. doi: 10.3109/10717544.2014.913733. Epub 2014 May 20.
4
Microsphere design for the colonic delivery of 5-fluorouracil.
J Control Release. 2003 Jul 31;90(3):313-22. doi: 10.1016/s0168-3659(03)00195-0.
7
Tailoring of drug delivery of 5-fluorouracil to the colon via a mixed film coated unit system.
Acta Pharm. 2011 Sep 1;61(3):343-51. doi: 10.2478/v10007-011-0023-5.
8
10
Colonic drug delivery of 5-fluorouracil: an in vitro evaluation.
Int J Pharm. 2004 Jan 9;269(1):101-8. doi: 10.1016/j.ijpharm.2003.09.036.

引用本文的文献

1
Solid lipid Lyo-Nanosuspension: A promising stabilized oral delivery system for the antihyperglycemic extract of mistletoe .
Saudi Pharm J. 2023 Aug;31(8):101689. doi: 10.1016/j.jsps.2023.06.022. Epub 2023 Jun 26.
2
Smart Pellets for Controlled Delivery of 5-Fluorouracil.
Molecules. 2022 Dec 30;28(1):306. doi: 10.3390/molecules28010306.
4
Oxidation of Drugs during Drug Product Development: Problems and Solutions.
Pharmaceutics. 2022 Jan 29;14(2):325. doi: 10.3390/pharmaceutics14020325.
5
Formulation, Optimization, and Evaluation of Saxagliptin-Loaded Lipospheres for an Improved Pharmacokinetic Behavior.
Biomed Res Int. 2021 Oct 20;2021:3849093. doi: 10.1155/2021/3849093. eCollection 2021.
7
Evaluation of Low Molecular Weight Cross Linked Chitosan Nanoparticles, to Enhance the Bioavailability of 5-Flourouracil.
Dose Response. 2021 Jul 28;19(2):15593258211025353. doi: 10.1177/15593258211025353. eCollection 2021 Apr-Jun.
10
Development and characterization of novel site specific hollow floating microspheres bearing 5-Fu for stomach targeting.
ScientificWorldJournal. 2014;2014:705259. doi: 10.1155/2014/705259. Epub 2014 Oct 14.

本文引用的文献

3
Peroxide formation in polysorbate 80 and protein stability.
J Pharm Sci. 2002 Oct;91(10):2252-64. doi: 10.1002/jps.10216.
6
Peroxide accumulation in detergents.
J Biochem Biophys Methods. 1994 Jul;29(1):77-81. doi: 10.1016/0165-022x(94)90058-2.
7
Protein crystallization: the growth of large-scale single crystals.
Methods Enzymol. 1984;104:370-81. doi: 10.1016/s0076-6879(84)04104-5.
8
Degradation of fenprostalene in polyethylene glycol 400 solution.
J Pharm Sci. 1984 Oct;73(10):1414-7. doi: 10.1002/jps.2600731023.
9
A stability study of chloramphenicol in topical formulations.
J Pharm Pharmacol. 1970 Aug;22(8):607-11. doi: 10.1111/j.2042-7158.1970.tb10577.x.
10
Use of polyethylene glycol in the crystallization of macromolecules.
Methods Enzymol. 1985;114:120-5. doi: 10.1016/0076-6879(85)14008-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验